Arcutis Biotherapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Westlake Village, CA
ARQT chart
What traders are saying about $ARQT
Latest postsArcutis Biotherapeutics, Inc. news
- Arcutis Biotherapeutics at Guggenheim conference: growth story expands By Investing.com
Investing.com UK ·
- Arcutis Biotherapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-11-09
Seeking Alpha ·
- Arcutis Biotherapeutics Inc (ARQT) (Q3 2026) Earnings Call Highlights: Revenue Surges 45% to ...
Yahoo Finance ·
- Arcutis Biotherapeutics Stock In Focus After Raised Guidance
Simply Wall St ·
- Arcutis Biotherapeutics Stock Price Forecast. Should You Buy ARQT?
StockInvest.us ·
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Arcutis Biotherapeutics (ARQT) Raised 2026 Sales Guidance, Is The Upside Already Priced In?
Yahoo Finance ·
- Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
Yahoo Finance ·
- Arcutis Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $39.62, Implies 16% Upside
TradingView ·
- Morgan Stanley Initiates Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Announces Target Price $38
Moomoo ·
- Arcutis Biotherapeutics, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis
Yahoo Finance ·
Arcutis Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $376.1M | $196.5M | $59.6M | $3.7M |
| Net income | -$16.1M | -$140.0M | -$262.1M | -$311.5M |
| Diluted EPS | $-0.13 | $-1.16 | $-3.78 | $-5.66 |
| Total assets (year end) | $433.0M | $348.9M | $341.4M | $449.3M |
| Cash and equivalents (year end) | $42.9M | $71.3M | $88.4M | $53.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arcutis Biotherapeutics, Inc.
- Ticker
- ARQT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Westlake Village, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787306
- Former names
- Arcutis, Inc.
Frequently asked questions
What exchange is Arcutis Biotherapeutics, Inc. listed on?
Arcutis Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol ARQT.
What industry is Arcutis Biotherapeutics, Inc. in?
Arcutis Biotherapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcutis Biotherapeutics, Inc. headquartered?
Arcutis Biotherapeutics, Inc.'s business address on file with the SEC is in Westlake Village, CA.
When does Arcutis Biotherapeutics, Inc.'s fiscal year end?
Arcutis Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Arcutis Biotherapeutics, Inc. report?
Arcutis Biotherapeutics, Inc. reported $376.1M in revenue for calendar year 2025, according to its SEC filings.